Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivani Pauli

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|February 19, 2014
Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agentsRafaela S Ferreira, Marco A Dessoy, Ivani Pauli, et al.
Future Medicinal Chemistry|May 17, 2017
Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitorsIvani Pauli, Leonardo G Ferreira, Mariana L de Souza, et al.
Journal of Structural Biology|November 26, 2009
Crystal structure and molecular dynamics studies of human purine nucleoside phosphorylase complexed with 7-deazaguanineRafael Andrade Caceres, Luis Fernando Saraiva Macedo Timmers, Ivani Pauli, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Identification of a Prenyl Chalcone as a Competitive Lipoxygenase Inhibitor: Screening, Biochemical Evaluation and Molecular Modeling StudiesMaria Luiza Zeraik, Ivani Pauli, Luiz A Dutra, et al.
Bioorganic Chemistry|March 21, 2021
Chalcones and their B-aryl analogues as myeloperoxidase inhibitors: In silico, in vitro and ex vivo investigationsMariana Bastos Dos Santos, Beatriz Carvalho Marques, Gabriela Miranda Ayusso, et al.
Frontiers in Chemistry|December 12, 2019
Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-<i>Trypanosoma cruzi</i> ActivityRafael A A Ferreira, Ivani Pauli, Thiago S Sampaio, et al.
Journal of Chemical Information and Modeling|July 30, 2013
Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approachIvani Pauli, Ricardo N dos Santos, Diana C Rostirolla, et al.
Scientific Reports|April 25, 2017
Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzymeLeonardo K B Martinelli, Mariane Rotta, Anne D Villela, et al.
Frontiers in Pharmacology|January 24, 2022
Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With <i>In Vivo</i> Activity and Favorable PharmacokineticsIvani Pauli, Celso de O Rezende, Brian W Slafer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|February 19, 2014
Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agentsRafaela S Ferreira, Marco A Dessoy, Ivani Pauli, et al.
Future Medicinal Chemistry|May 17, 2017
Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitorsIvani Pauli, Leonardo G Ferreira, Mariana L de Souza, et al.
Journal of Structural Biology|November 26, 2009
Crystal structure and molecular dynamics studies of human purine nucleoside phosphorylase complexed with 7-deazaguanineRafael Andrade Caceres, Luis Fernando Saraiva Macedo Timmers, Ivani Pauli, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Identification of a Prenyl Chalcone as a Competitive Lipoxygenase Inhibitor: Screening, Biochemical Evaluation and Molecular Modeling StudiesMaria Luiza Zeraik, Ivani Pauli, Luiz A Dutra, et al.
Bioorganic Chemistry|March 21, 2021
Chalcones and their B-aryl analogues as myeloperoxidase inhibitors: In silico, in vitro and ex vivo investigationsMariana Bastos Dos Santos, Beatriz Carvalho Marques, Gabriela Miranda Ayusso, et al.
Frontiers in Chemistry|December 12, 2019
Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-<i>Trypanosoma cruzi</i> ActivityRafael A A Ferreira, Ivani Pauli, Thiago S Sampaio, et al.
Journal of Chemical Information and Modeling|July 30, 2013
Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approachIvani Pauli, Ricardo N dos Santos, Diana C Rostirolla, et al.
Scientific Reports|April 25, 2017
Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzymeLeonardo K B Martinelli, Mariane Rotta, Anne D Villela, et al.
Frontiers in Pharmacology|January 24, 2022
Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With <i>In Vivo</i> Activity and Favorable PharmacokineticsIvani Pauli, Celso de O Rezende, Brian W Slafer, et al.
Pageof 2